16 December 2021
INHSU Prisons is all too aware that many in our network continue to be out on the front line of the response to COVID-19. Many may not have been able to keep up-to-date with the most recent publications relating to hepatitis C and prisons, and due to last year’s success, we have decided to make creating a bibliography an annual activity.
As such, we have once again put together a list of the relevant publications from 2021 in our Annual INHSU Prisons Bibliography and highlighted those we consider to be of particular interest. Despite COVID-19, there has been a lot of research published in the field in 2021. Congratulations to all!
Articles of exceptional and outstanding interest
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort stud (exceptional).
Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, McHutchison JG, Brainard DM, Treloar C, Chambers GM, Grant L, Mcgrath C, Lloyd AR, Dore GJ; SToP-C study group.
Summary: DAA scale-up in Australian prisons was associated with reduced HCV incidence in prison indicating a beneficial effect of HCV treatment-as-prevention in correctional settings.
Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework (outstanding).
Akiyama MJ, Kronfli N, Cabezas J, Sheehan Y, Thurairajah PH, Lines R, Lloyd AR; International Network on Health and Hepatitis in Substance Users–Prisons Network.
Summary: This review led by INHSU Prisons highlights seven priority areas and best practices for improving HCV care in correctional settings: changing political will, ensuring access to HCV diagnosis and testing, promoting optimal models of HCV care and treatment, improving surveillance and monitoring of the HCV care cascade, reducing stigma and tackling the social determinants of health inequalities, implementing HCV prevention and harm reduction programmes, and advancing prison-based research.
Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences (outstanding).
Cabezas J, Llerena S, Mateo M, Álvarez R, Cobo C, González V, Martró E, Cuadrado A, Crespo J.
Summary: Micro-elimination programs using point of care diagnostic tests, telemedicine, and a navigator are necessary among populations serving non-custodial sentences.
The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases (outstanding).
Stöver H, Tarján A, Horváth G, Montanari L.
Summary: Availability and coverage of harm reduction interventions in European prisons are limited and scaling up harm reduction in prison and throughcare can achieve important individual and public-health benefits.
Brief Report: HCV Universal Test-and-Treat With Direct Acting Antivirals for Prisoners With or Without HIV: A Prison Health Care Workers-Led Model for HCV Microelimination in Thailand
Supanan R, Han WM, Harnpariphan W, Ueaphongsukkit T, Ubolyam S, Sophonphan J, Tangkijvanich P, Thanprasertsuk S, Avihingsanon A; HIV-NAT HCV Study Team.
Summary: Treatment of Thai prisoners using a universal test-and-treat approach led by prison health care workers was highly effective and safe.